Articles about Patients

• Eisai and Biogen announced positive top-line results from CLARITY AD trial extension on April 7, 2026, with lecanemab reducing cognitive decline by 27% over 18 months in 1,795 US patients. • Drug cleared 59% more amyloid plaques vs. placebo, with ARIA side effects in 12.6% of participants; full data at June AD/PD conference. • Approval could expand to mild cases, addressing 6.7 million US Alzheimer's sufferers; analysts predict $2.4 billion annual sales.

People encouraged to ‘come forward as normal’ when BMA members begin industrial action over pay on TuesdayThe NHS is urging patients not to put off seeking the care they need when resident doctors press ahead with strike action from Tuesday, a stoppage that the health secretary has called “disappointing”.Tens of thousands of resident doctors in England are to stage a six-day strike after the government took a key part of its offer off the table. Continue reading...

People receive rehab only three to four days a week in hospital – and one to two days once they are discharged, data suggestsThe NHS is failing stroke patients and limiting their chances of recovery because of a shortage of rehabilitation care staff, health leaders have said.More people are surviving strokes than ever before in the UK. But their hopes of getting better are being dashed because of a lack of physiotherapists and other specialist staff, according to the Chartered Society of Physiotherapy and the Association of Chartered Physiotherapists in Neurology. Continue reading...

• The SPIRIT-HF study, presented at ACC.26 in New Orleans (March 28-30, 2026), found that spironolactone increased hospitalizations and serious adverse events in patients with HFpEF (heart failure with preserved ejection fraction) or HFmrEF (mildly reduced ejection fraction). • Results raise significant safety questions about the drug's efficacy in these patient populations, potentially challenging current treatment protocols. • The findings were presented to cardiologists and cardiovascular specialists at the American College of Cardiology's annual conference, the largest gathering of heart disease specialists.

Patients experiencing raised bedside rails, doors and pathways blocked by furniture and physical interventionsPeople with dementia are being subjected to restraints and non-consensual sedation while in hospitals in England, according to the first study of its kind.These restrictive practices were found to be an “embedded aspect of routine ward care”, according to the analysis, with such examples including dementia patients having their bedside rails raised, doors and pathways blocked by furniture, experiencing verbal commands to sit down or go back to bed, and physical interventions such as non-consensual sedation. Continue reading...